INVOKANA
As listed in the register: INVOKANA 100 mg, comprimé pelliculé
102 mg · comprimé pelliculé
- Prescription only
- Active substance
- Canagliflozine Hémihydraté
- Made by
- JANSSEN CILAG INTERNATIONAL NV
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | JANSSEN CILAG INTERNATIONAL NV |
|---|---|
| Active substance | Canagliflozine Hémihydraté |
| Strength | 102 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/13/884 |
| Name in the register | INVOKANA 100 mg, comprimé pelliculé |
| Packs | 30 plaquette(s) thermoformée(s) PVC-Aluminium de 1 comprimé(s) |
| CIS | 64292898 |
| CIP13 | 3400927672897 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimé pelliculé2 products
- 102 mg
- 306 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.